0001354457-22-000797.txt : 20221229
0001354457-22-000797.hdr.sgml : 20221229
20221229093555
ACCESSION NUMBER: 0001354457-22-000797
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20221229
DATE AS OF CHANGE: 20221229
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001466301
Clovis Oncology, Inc.
001-35347
2525 28th Street
Suite 100
Boulder
CO
COLORADO
80301
303-625-5000
Common Stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2022-12-29
EX-99.25
2
clvsdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC,
December 29, 2022, Clovis Oncology, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined
to remove from listing the common stock of Clovis Oncology,
Inc. (the Company), effective at the opening of the trading
session on January 9, 2023.
Based on review of information provided by the Company,
Exchange Staff determined that the Company no longer qualified
for listing on the Exchange pursuant to Listing Rules 5101,
5110(b), and IM-5101-1.
The Company was notified of the Staff determination on December
12, 2022. The Company did not appeal the Staff determination to
the Hearings Panel. The Staff determination to delist the
Company securities became final on December 21, 2022.